Terumo Website Feed

Terumo India Partners with Siemens Healthineers to Introduce First of Its Kind Programme for Cathlab Directors in Collaboration with ISB Executive Education
Notice Concerning the Issuance of Stock Options (Share Warrants)
Olympus and Terumo Announce Change in Form of Contract
Hundreds of sickle cell patients to benefit from £1.5M technology investment
Notice Regarding Disposal of Treasury Shares as Restricted Stock Remuneration
Terumo Blood and Cell Technologies’ IMUGARD Platelet Pooling Set Cleared by FDA
Terumo India recognized among India's Great Mid-Size Workplaces™
Notice Concerning the Status of the Acquisition of Own Shares
Terumo India Certified as Great Place to Work® for The Third Time
Notice Concerning the Issuance of Stock Options (Share Warrants)
Terumo to Further Drive DE&I by Establishing Focus Areas to Commit Globally
MicroVention Celebrates One-Year Anniversary of FRED™ X Flow Diverter with Over 1,000 Patients Treated Across the U.S.
Terumo India Advances Liver Cancer Care in India with the Launch of Occlusafe™ & LifePearl™
Terumo Blood and Cell Technologies-sponsored panel publishes first-of-its-kind international consensus recommendations for pregnancy complications in patients with sickle cell disease
MicroVention Announces Release of CLinical EValuation of WEB™ 17 Device in Intracranial Aneurysms (CLEVER): One Year Effectiveness Results for Ruptured and Unruptured Aneurysms
Notification of Completion of Acquisition and Cancellation of Own Shares
Terumo Prospective Registry Reinforces Safety, Efficacy and Efficiency of Radial Access in Visceral Interventions (R.A.V.I.) in Embolization Procedures
MicroVention Announces 5-Year Clinical Trial Data and Size Additions for its WEB Aneurysm Embolization System; WEB is Most Well-Studied Intrasaccular Device Available Today
908 Devices and Terumo Blood and Cell Technologies Collaborate to Add On-line Analytics to Quantum Flex Cell Expansion System
Notice Concerning the Status of the Acquisition of Own Shares
Terumo India Wins Big For Its Health & Wellbeing Initiatives
Ultimaster Drug Eluting Stent family (Terumo) first stent to receive the mention 1-month DAPT in the reimbursement conditions in France
Notice Concerning Partial Amendments to the Articles of Incorporation
Terumo Blood and Cell Technologies’ Reveos® Automated Whole Blood Processing System Cleared by FDA for U.S. Commercial Use
Terumo India Introduces Insulin Syringe for Patients Requiring Daily Insulin Injections to Manage Diabetes
Notice Concerning the Status and Completion of the Acquisition of Own Shares and Cancellation of Treasury Stock
Notice Concerning the Determination of Details of Issuance of Stock Options (Share Warrants)
Terumo Announces Launch of Drug-Device Combination Product Co-Developed with Kyowa Kirin
Terumo Group’s Targets for Greenhouse Gas Reduction Approved by the SBT Initiative as 1.5°C Aligned
Notice of Completion of Disposal of Treasury Shares as Restricted Stock Remuneration Plan
Terumo expands global presence with new subsidiary in South-Africa
Notice Concerning Partial Amendment to “Notice Concerning Share Split and Partial Amendment to the Articles of Incorporation”
Notice Concerning Completion of Disposal of Treasury Shares as Restricted Stock Remuneration
Notification Regarding Status of Acquisition of the Company's Own Shares
Terumo Aortic Announces First Implant of Innovative Custom-made Thoracoabdominal Hybrid Device in North America
Notice Concerning the Determination of Details of Issuance of Stock Options (Share Warrants)
Notice Concerning the Status of the Acquisition of Own Shares
Terumo Blood and Cell Technologies partners with CiRA Foundation to develop automated iPS cell manufacturing
Terumo Establishes Corporate Venture Capital “Terumo Ventures”
Terumo Announces All Dexcom G6 CGM System Users on Insulin Therapy to be Covered by Insurance in Japan
Ultimaster Nagomi™ MDR certification and launch of large-scale post-market study investigating the new coronary stent system in complex PCI
Notice Concerning Acquisition of Own Shares and Cancellation of Treasury Stock
Terumo Blood and Cell Technologies takes part in Connecting the Dots
FDA Clears the Individualized Nomogram for Rika Plasma Donation System
First Patient Treated and Enrolled in Terumo Medical Corporation’s Osprey Iliac IDE Clinical Trial
Terumo Aortic Announces FDA Approval of Dissection and Transection Indication Expansion for the RELAY®Pro Stent-graft System in the United States
Notice of Stock Change of Olympus Terumo Biomaterials
Terumo Medical Corporation’s New AZUR HydroPack™ Peripheral Coil System Provides a Soft-Packing, Long-Lasting Solution to Embolotherapy
Terumo Appoints the Candidates for Directors
Terumo and Siemens Healthineers India collaborate to strengthen cardiac care in India
Terumo to Construct a New Manufacturing Facility at its Kofu Factory for the Medical Care Solutions Company
Notice Concerning the Status of the Acquisition of Own Shares
Notice Concerning the Change of Executive Officers as of April 1, 2024
Terumo Aortic Receives Prestigious King’s Award for Innovation
Terumo Group to Establish the Sustainability Committee
Terumo Appoints the Candidates for Directors
Terumo Group Associates Celebrate Terumo Patient’s Day 2023
Notice Concerning the Status of the Acquisition of Own Shares
Terumo Cardiovascular Announces 510(K) Clearance For The CDI OneView™ Monitoring System
Terumo to Revise Performance Evaluation System for Executive Officers
Terumo Blood and Cell Technologies Optimizing Cell Therapy Production Through Industry’s First Apheresis Training for Cell Therapy Manufacturers
CI&T TEST-PR: News Release private image
Notice Concerning the Status of the Acquisition of Own Shares
NICE PUBLISHES A GUIDANCE SUPPORTING THE USE OF SELECTIVE INTERNAL RADIATION THERAPY FOR NEUROENDOCRINE TUMORS WITH LIVER METASTATIS
Terumo Announces Change of Executive Officers
Terumo Aortic Announces Launch of the Global Thoraflex Hybrid EXTEND Study
Terumo to Cease Distributing Dexcom Continuous Glucose Monitoring Systems as Dexcom Moves to a Direct Distribution Model in Japan
Notice Concerning Revision of the Full-Year Financial Guidance for Fiscal Year Ending March 31, 2024 (FY2023)
Terumo Announces Voting Results for the Election of Directors
Notice Concerning Revision of the Year-end Dividend Forecast for Fiscal Year Ending March 31, 2023 (Dividend Increase)
Terumo Announces Voting Results for the Election of Directors
Notice Concerning the Status of the Acquisition of Own Shares
Terumo Announces Change of Executive Officers
MicroVention Announces the Next Evolution in Stent Innovation: MicroVention’s LVIS™ EVO™ Intraluminal Support Device Now Available in the United States
Notice Concerning Revision of the Full-Year Financial Guidance for Fiscal Year Ending March 31, 2023 (FY2022)
Terumo Aortic Announces PMDA Approval for Thoraflex Hybrid in Japan
Terumo Blood and Cell Technologies launches study with BioCentriq® to generate public CAR-T cell data using Terumo BCT’s CGT manufacturing platforms
Notice Concerning Share Split and Partial Amendment to the Articles of Incorporation
NICE PUBLISHES NEW GUIDANCE SUPPORTING THE USE OF HOLMIUM-166 SELECTIVE INTERNAL RADIATION THERAPY FOR UNRESECTABLE ADVANCED HEPATOCELLULAR CARCINOMA
Terumo Blood and Cell Technologies Presents First Quantum Flex Data for Multiple Size Bioreactors Showing Rapid T-Cell Expansion to Numbers Equivalent to a Therapeutic Dose
Notice Regarding Disposal of Treasury Shares as Restricted Stock Remuneration
ANGIO-SEAL™ VIP & FEMOSEAL™ VASCULAR CLOSURE DEVICES SECURED CE CERTIFICATE UNDER THE NEW MEDICAL DEVICE REGULATION
Terumo Medical Corporation Breaks Ground on New Manufacturing Site at Its Puerto Rico Location
Terumo Blood and Cell Technologies celebrates 60 years as a community-first Colorado company
View all